Download PDF
Synlett 2011(1): 84-88  
DOI: 10.1055/s-0030-1259098
LETTER
© Georg Thieme Verlag Stuttgart ˙ New York

A Concise and Convergent Synthesis of Luotonin B and E

Manoj Balu Wagha, R. Shankara, U. K. Syam Kumar*a, C. H. Gillb
a Technology Development Centre, Custom Pharmaceutical Services, Dr. Reddy’s Laboratories Ltd, Hyderabad 500049, India
Fax: +91(40)23045439; e-Mail: syam_kmr@yahoo.com;
b Dr. Babasaheb Ambedkar University, Aurangabad, Maharashtra 431004, India
Further Information

Publication History

Received 31 August 2010
Publication Date:
10 December 2010 (online)

    Permissions and Reprints All articles of this category

Abstract

A concise and highly convergent practical synthesis of topoisomerase 1 inhibitor luotonin B was developed in a one-pot process in excellent yields. The C and D rings of luotonin B was constructed by cascade cyclizations of 2-cyanoquinoline-3-aldehyde or 2-cyanoquinoline-3-hemiacetal with methylanthranilate under acidic conditions. The luotonin B was then converted into luotonin E by an acid-catalyzed etherification reaction.

Key words

luotonin A - B and E alkaloids - camptothecin - 2-cyanoquinoline-3-aldehyde - 2-cyanoquinoline-3-acetal - methyl anthranilate - cascade cyclization

    References and Notes

  • 1a Wall ME. Wani MC. Cook CE. Palmer KH. McPhail AT. Sim GA. J. Am. Chem. Soc.  1966,  88:  3888 
    Google Scholar
  • 1b Govindachari TR. Viswanathan N. Indian. J. Chem.  1972,  10:  453 
    Google Scholar
  • 1c Ma ZZ. Hano Y. Nomura T. Chen YJ. Heterocycles  1997,  46:  541 
    Google Scholar
  • 1d Ma ZZ. Hano Y. Nomura T. Chen YJ. Heterocycles  1999,  51:  1883 
    Google Scholar
  • 2 Ali MM. Tasneem KC. Rajanna PK. . Synlett  2001,  251 
    Google Scholar
  • 3a Amin AH. Mehta DR. Samarth SG. Prog. Drug Res.  1970,  14:  218 
    Google Scholar
  • 3b Johne S. Prog. Drug Res.  1982,  26:  259 
    Google Scholar
  • 4 Cagir A. Jones SH. Gao R. Eisenhauer BM. Hecht SM. J. Am. Chem. Soc.  2003,  125:  13628 
    CrossrefGoogle Scholar
  • 5a Zhao H. Lee C. Sai P. Choe YH. Boro M. Pendri A. Guan S. Greenwald RB. J. Org. Chem.  2000,  65:  4601 
    Google Scholar
  • 5b Fassberg J. Stella VJ. J. Pharm. Sci.  1992,  81:  676 
    Google Scholar
  • 5c Burke TG. Mi Z. Anal. Biochem.  1993,  212:  285 
    Google Scholar
  • 5d Burke TG. Mi Z. J. Med. Chem.  1994,  37:  40 
    Google Scholar
  • 6a Suresh Babu M. Raghunadh A. Anil Kumar N. Syam Kumar UK. Vasu Dev R. Dubey PK.
    J. Heterocycl. Chem.  2010,  47:  in press
    Google Scholar
  • 6b Sawada S. Okajima S. Aiyama R. Nokota K. Furuta T. Yokokura T. Sugino E. Yamaguchi K. Miyasaka T. Chem. Pharm. Bull.  1991,  39:  1446 
    Google Scholar
  • 6c Kingsbury WD. Boehm JC. Jacas DR. Holden KG. Hecht SM. Gallagher G. Caranfa MJ. McCabe FL. Faucette LF. Johnson RP. Hertzberg RP. J. Med. Chem.  1991,  34:  98 
    Google Scholar
  • 6d Subrahmanyam D, Venkateswarlu A, Sarma VM, Sastry TVRS, Krishna CV, and Madabhushi S. inventors; US 6177439  B1. 
  • 6e Subrahmanyam D. Sarma VM. Venkateswarlu A. Sastry TVRS. Srinivas ASSV. Krishna CV. Deevi DS. Kumar SA. Babu MJ. Damodaran NK. Bioorg. Med. Chem. Lett.  2000,  10:  369 
    Google Scholar
  • 6f Subrahmanyam D. Venkateswarlu A. Venkateswarao K. Sastry TVRS. Vandana G. Kumar SA. Bioorg. Med. Chem. Lett.  1999,  9:  1633 
    Google Scholar
  • 6g Kim D.-K. Lee N. Mini Rev. Med. Chem.  2002,  2:  611 
    Google Scholar
  • 6h Hatefi A. Amsden B. Pharm. Res.  2002,  19:  1389 
    Google Scholar
  • 7a Servais A. Azzouz M. Lopes D. Courillon C. Malacria M. Angew. Chem. Int. Ed.  2007,  46:  576 
    Google Scholar
  • 7b Beaume A. Courillon C. Derat E. Malacria M. Chem. Eur. J.  2008,  16:  1228 
    Google Scholar
  • 8 Twin H. Batey R. Org. Lett.  2004,  6:  4913 
    CrossrefPubMedGoogle Scholar
  • 9a Nacro K. Zha CC. Guzzo PR. Herr J. Peace D. Friedrich TD. Bioorg. Med. Chem.  2007,  13:  4237 
    Google Scholar
  • 9b Harayama T. Hori A. Serban G. Morikami Y. Matsumoto T. Abe H. Takeuchi Y. Tetrahedron  2004,  60:  10645 
    Google Scholar
  • 9c Mason JJ. Bergman J. Org. Biomol. Chem.  2007,  5:  2486 
    Google Scholar
  • 9d Mhaske SB. Argade NP. J. Org. Chem.  2004,  69:  4563 
    Google Scholar
  • 9e Chavan SP. Sivappa R. Tetrahedron  2004,  60:  9931 
    Google Scholar
  • 9f Mhaske SB. Argade PN. J. Org. Chem.  2004,  69:  4563 
    Google Scholar
  • 10 Zhou H.-B. Liu G.-S. Yao Z.-J. J. Org. Chem.  2007,  73:  6270 
    Google Scholar
  • 11 Sridharan V. Ribelles P. Ramos T. Menendez JC.
    J. Org. Chem.  2009,  74:  5715 
    CrossrefPubMedGoogle Scholar
  • 12a Baruah B. Bhuyan JP. Tetrahedron  2009,  65:  7099 
    Google Scholar
  • 12b Baruah B. Deb ML. Bhuyan PJ. Synlett  2007,  1873 
    Google Scholar
  • 13a Jana GP. Ghorai BK. Tetrahedron  2007,  63:  12015 
    Google Scholar
  • 13b Chavan SP. Pasupathy K. Sivappa R. Venkatraman MS. Synth. Commun  . 2004,  34:  3099 
    Google Scholar
  • 13c Chavan SP. Sivappa R. Tetrahedron Lett.  2004,  45:  3113 
    Google Scholar
  • 14 Takao S. Kazutoshi O. J. Chem. Soc., Perkin Trans. 1  1999,  16:  2323 
    Google Scholar
15

To a suspension of 2-cyanoquinoline-3-acetal (9, 1 g, 0.004 mol, 1 equiv) in AcOH (10 mL), methyl anthranilate (0.7 g, 0.005 mol, 1.05 equiv) was added, and the reaction mixture was heated to reflux for a period of 12-14 h. The reaction mass was then cooled, the precipitated product was filtered off, and further purified by column chromatography using EtOAc and hexane (7:3) to yield the lutonin B. The filtrate was diluted with H2O, and extracted with EtOAc, and dried. Concentration and purification by column chromatography yielded 11.

16

To a suspension of cyanoaldehyde (1 g, 0.5 mmol, 1 equiv) in AcOH (10 mL) and Ac2O (0.2 mL), methyl anthranilate (0.554 g, 0.71 mmol, 1.5 equiv) was added, and the reaction mixture was heated to reflux for a period of 12-14 h. The reaction mass was then cooled to r.t., and precipitated product was filtered off. The mother liquor was then diluted with H2O, and extracted with EtOAc. The precipitated product mixture and the EtOAc extracts were combined together, concentrated under vacuum. The product was then purified by column chromatography using EtOAc and hexane (7:3), and pure luotonin B was isolated as white to off-white solid in 0.890 g, 54% of yield. Also 12% of 11 was also isolated from the column.

17

Methyl-2-(11-oxo-11,13-dihydroquinolino[2′,3′:3,4]-pyrrolo[2,1- b ]quinazolin-13-yl)amino benzoate (11) Yield 20%; mp 312-314 ˚C. ¹H NMR (400 MHz, CDCl3):
δ = 3.80 (s, 3 H), 6.77 (t, J = 7.2 Hz, 1 H), 7.26 (s, 1 H), 7.27 (s, 1 H), 7.35 (t, J = 7.6 Hz, 1 H), 7.52 (t, J = 6.8 Hz, 1 H), 7.69 (t, J = 7.6 Hz, 1 H), 7.80-7.97 (m, 4 H), 8.1 (d, J = 8.0 Hz, 1 H), 8.34 (dd, J = 1.6, 7.8 Hz, 1 H), 8.48 (s, 1 H) 8.52 (d, J = 8.8 Hz, 1 H), 8.85 (d, J = 9.6 Hz, 1 H). ¹³C NMR (400 MHz, CDCl3): δ = 51.8, 68.4, 112, 113.6, 117.6, 122.4, 126.7, 127.6, 128.4, 128.6, 128.8, 129.1, 130.8, 131.2, 131.7, 132.2, 132.6, 134.4, 134.6, 148.0, 149.0, 150.0, 150.4, 151.4, 160.6, 168.9. MS: m/z (%) = 435 [M + 1], 302.2, 137.1. Anal Calcd for C26H18N4O3: C, 71.88; H, 4.18; N, 12.90. Found: C, 71.86; H, 4.15; N, 12.87.

18

Luotonin B (2)
Yield 0.89 g (54%); mp 273-275 ˚C. IR (KBr): 1028, 1266, 1449, 2041, 2945, cm-¹. ¹H NMR (400 MHz, DMSO-d 6):
δ = 6.98 (d, J = 8.4 Hz, 1 H), 7.62-7.66 (m, 2 H), 7.78 (t, J = 7.2 Hz, 1 H), 7.92-7.96 (m, 3 H), 8.23 (d, J = 8.0 Hz, 1 H), 8.28 (dd, J = 3.6 Hz, 8.4 Hz, 2 H), 8.80 (s, 1 H). ¹³C NMR (400 MHz, DMSO-d 6): δ = 80.5, 122.2, 126.1, 127.5, 128.2, 128.3, 128.7, 128.8, 129.6, 131.0, 132.8, 133.8, 134.7, 148.7, 149.1, 150.3, 151.5, 159.4. MS m/z (%) = 302.1 [M + 1], 246.2, 150.1. Anal Calcd for C18H11N3O2: C, 71.75; H, 3.68; N, 13.95. Found: C, 71.77; H, 3.69; N, 13.90.

19

To a solution of luotonin B (0.35 g, 0.16 mol, 1 equiv) in MeOH (3.5 mL, 10 V), Indion resin (0.1 g, 0.01 mmol, 0.1 equiv) was added, and the reaction mixture was heated at 55 ˚C for a period of 6-7 h. The reaction mixture was then cooled, and the resin was filtered off and washed with MeOH (1 mL). The filtrate was concentrated under reduced pressure, and purified on a filter column using EtOAc-hexane (30:70). The product was isolated as a white to off-white solid in 80% (0.29 g) yield.
Luotonin E Yield 0.29 g (80%).; mp 222-224 ˚C. IR (KBr): 1047, 1237, 1300, 1375, 1730, 2985 cm-¹. ¹H NMR (400 MHz, CDCl3): δ = 3.60 (s, 3 H), 6.90 (s, 1 H), 7.58 (dt, J = 0.8, 7.6, 11.2 Hz, 1 H), 7.71 (t, J = 6.8 Hz, 1 H), 7.82-7.88 (m, 2 H), 7.99 (d, J = 8.4 Hz, 1 H), 8.09 (d, J = 8.0 Hz, 1 H) 8.41 (dd, J = 1.2, 8.0 Hz, 1 H), 8.47 (d, J = 8.4 Hz, 1 H), 8.5 (s, 1 H). ¹³C NMR (400 MHz, CDCl3): δ = 56.3, 87.0, 122.2, 126.8, 127.8, 128.4, 128.6, 128.8, 130.0, 130.7, 131.3, 133.0, 134.8, 148.9, 150.4, 151.3, 160.7. MS: m/z (%) = 316.2 [M + 1], 279.2, 130.2. Anal Calcd for C19H13N3O2: C, 72.37; H, 4.16; N, 13.33. Found: C, 72.34; H, 4.15; N, 13.35.

20

Tetrahydroluotonin A (20) Yield 190 mg (50%); mp 191-193 ˚C. ¹H NMR (400 MHz, CDCl3): δ = 2.57 (dd, J = 8.0, 14.8 Hz, 1 H), 2.95-3.06 (m, 2 H), 4.03 (dd, J = 4.0, 12.0 Hz, 1 H), 4.33 (dd, J = 6.8, 12 Hz, 1 H), 4.66 (s, 1 H), 4.81 (dd, J = 3.2, 7.8 Hz, 1 H), 6.65 (d, J = 6.7 Hz, 1 H), 6.70 (dd, J = 0.4, 10.6 Hz, 1 H), 7.01 (m, 2 H) 7.45 (m, 1 H), 7.72-7.80 (m, 2 H), 8.29 (d, J = 8.4 Hz, 1 H). ¹³C NMR (400 MHz, CDCl3): δ = 28.5, 31.6, 49.7, 57.6, 114.3, 118.6, 120.0, 121.1, 126.4, 126.7, 127.1, 127.6, 128.8, 134.2, 142.6, 149.2, 159.5, 160.9. MS: m/z (%) = 435 [M + 1], 290.2, 202.2, 186.2. Anal Calcd for C18H15N3O: C, 74.72; H, 5.23; N, 14.52. Found: C, 74.70; H, 5.21; N, 14.57.